REPLIGEN CORPORATION - COMMON STOCK
118.07
30-May-25 13:45:00
15 minutes delayed
Stocks
-4.25
-3.47%
Today's range
117.11 - 121.88
ISIN
N/A
Source
NASDAQ
-
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
26 Sep 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Jason K. Garland as Chief Financial Officer
12 Sep 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Wells Fargo Healthcare Conference
01 Sep 2023 04:30:00 By Nasdaq GlobeNewswire
-
17 Aug 2023 05:00:00 By Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 Aug 2023 04:30:01 By Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2023 Financial Results
19 Jul 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
31 May 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 May 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2023 Financial Results
18 Apr 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
14 Mar 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
22 Feb 2023 04:30:01 By Nasdaq GlobeNewswire
-
Repligen Appoints Martin D. Madaus to Board of Directors
09 Feb 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 Feb 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
08 Nov 2022 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
01 Nov 2022 04:30:01 By Nasdaq GlobeNewswire
-
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands
01 Nov 2022 04:00:01 By Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2022 Financial Results
12 Oct 2022 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
19 Sep 2022 13:01:00 By Nasdaq GlobeNewswire
-
Repligen To Host Investor Day 2022
24 Aug 2022 04:30:00 By Nasdaq GlobeNewswire